Serum-free culture fluid for enhancing immunosuppression function of animal mesenchymal stem cells
A serum-free culture medium and serum-free culture technology, applied in animal cells, vertebrate cells, bone/connective tissue cells, etc., can solve the limited nutritional promotion effect of animal mesenchymal stem cells, without considering the impact of immunosuppressive effects , poor reproducibility of products and experimental results, etc., to achieve the effect of favoring differentiation, stabilizing signal transduction pathways, and avoiding toxic effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] Human bone marrow-derived mesenchymal stem cells were co-cultured with mouse-derived activated T cells, and the culture medium used was respectively 10% FBS-MSCGM medium and animal mesenchymal stem cell serum-free medium (SF-MSCGM) of the present invention for cultivation. The composition of the invented SF-MSCGM is as follows: basal culture medium + proliferation factors (bFGF, HGF, TGF-β3, PDGF-BB) + CD + cholesterol + VE + lecithin + dexamethasone + transferrin + selenous acid + BSA + insulin + INF -γ+TNF-α. For the T cell proliferation response stimulated by anti-CD3 and CD28, the results show that the human mesenchymal stem cells cultivated with the serum-free medium of the present invention have an immunosuppressive effect ( Figure 1-a , Figure 1-b ).
Embodiment 2
[0054] Take human bone marrow-derived mesenchymal stem cells and mouse-derived activated T cells for co-cultivation, and the culture medium used is respectively 10% FBS-MSCGM culture medium and animal mesenchymal stem cell immunosuppression of the present invention can enhance serum-free culture medium (SF-MSCGM) , The composition of SF-MSCGM of the present invention is the same as in Example 1. For the T cell proliferation response stimulated by anti-PMA / Ionomyein, the results show that human mesenchymal stem cells cultivated with serum-free medium of the present invention have immunosuppressive effect ( Figure 2-a , Figure 2-b ).
Embodiment 3
[0056] Experiment of immunosuppressive effect of hMSC derived from bone marrow on T cell proliferation under mixed lymphocyte reaction (MLR) of mice. The experimental method, the cells used, and the culture medium used are all the same as in Example 1. The treatment method of hMSC derived from bone marrow is to sow 2×10 cells in each well of 96 wells. 4 cells at a density; the activation method of mouse spleen cells is to use 2×10 4 Density mouse spleen cells were co-cultured with mouse bone marrow-derived dendritic cells (BMDC), and the seeding density of the latter was 3.3×10 4 pcs / hole. The results of the examples show that the bone marrow-derived hMSCs cultured with SF-MSCGM of the present invention have the same immunosuppressive effect as the bone marrow-derived hMSCs cultured with MSCGM medium; Figure 3-b ), while the bone marrow-derived hMSCs cultured with SF-MSCGM of the present invention began to exhibit immunosuppressive effect from day 3 ( Figure 3-a ). That ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com